US3953291A - Process for preparing 6-aminopenicillanic acid - Google Patents

Process for preparing 6-aminopenicillanic acid Download PDF

Info

Publication number
US3953291A
US3953291A US05/450,655 US45065574A US3953291A US 3953291 A US3953291 A US 3953291A US 45065574 A US45065574 A US 45065574A US 3953291 A US3953291 A US 3953291A
Authority
US
United States
Prior art keywords
acryloylamide
bis
producing microorganism
penicillin
penicillin amidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US05/450,655
Other languages
English (en)
Inventor
Ichiro Chibata
Tetsuya Tosa
Tadashi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of US3953291A publication Critical patent/US3953291A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/829Alcaligenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/859Micrococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/874Pseudomonas
    • Y10S435/875Pseudomonas aeruginosa
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/897Streptomyces griseus

Definitions

  • This invention relates to a process for preparing 6-aminopenicillanic acid. More particularly, it relates to the production of 6-aminopenicillanic acid (hereinafter referred to simply as "6-APA") by enzymatic reaction of an immobilized penicillin amidase-producing microorganism with penicillin.
  • 6-APA 6-aminopenicillanic acid
  • 6-APA is prepared by enzymatic deacylation of penicillin, i.e., by the reaction of penicillin with penicillin amidase or a penicillin amidase-producing microorganism.
  • this method is disadvantageous for a large scale production.
  • 6-APA produced according to this method is contaminated with the enzyme, microbial cells, nutrient sources and/or proteins. Accordingly, additional steps of removing the enzyme, microbial cells and/or other contaminants from the product are required to recover 6-APA in high purity.
  • the reaction solution is boiled and/or acidified to destroy the enzyme or microorganism, and precipitates of the enzyme or microorganism are filtered off.
  • 6-APA is prepared by chemical deacrylation of penicillin.
  • penicillin is reacted with triphenylmethyl chloride to give triphenylmethyl ester of penicillin.
  • Said ester is treated with phosphorus trichloride.
  • the triphenylmethyl ester of N imino -chloro-penicillin thus obtained is reacted with methanol to give the corresponding N imino -methoxy-penicillin ester.
  • 6-APA is obtained by hydrolyzing said N imino -methoxy-penicillin ester with aqueous ammonia.
  • this chemical method is also disadvantageous because of lengthy procedures involved therein and/or low yield of 6-APA to be obtained.
  • 6-APA can be prepared by the steps of polymerizing at least one acryloyl monomer in an aqueous suspension of a penicillin amidase-producing microorganism, and subjecting the resultant immobilized penicillin amidase-producing microorganism to enzymatic reaction with penicillin.
  • Preferred examples of the penicillin amidase-producing microorganisms which are employed in the present invention include Escheichia coli ATCC 9637, Escherichia coli ATCC 11105, Streptomyces griseus IFO (Institute for Fermentation, Osaka, Japan) 3355, Nocardia gardneri ATCC 9604, Micrococcus roseus IFO 3764, Pseudomonas aeruginosa OUT (Faculty of Technology, Osaka University, Japan) 8252 and Alkaligenes faecalis OUT 8025. All of these microorganisms are publicly available from the above-mentioned depositories.
  • the present invention is not limited to the use of these specific microorganisms, but includes within its scope the use of all of penicillin amidase-producing microorganisms such as those belonging to the genera of Escherichia, Streptomyces, Nocardia, Alkaligenes, Micrococcus and Pseudomonas.
  • Suitable amount of the penicillin amidase-producing microorganism which is employed in the present invention is 0.32 to 3.2 g, especially 0.95 to 1.9 g, per g of the acryloyl monomer or monomers used.
  • the polymerization reaction of the present invention serves to tightly entrap each of the microorganisms into the lattice of the polymer thereby affording high enzymatic activity for a long period of time.
  • the polymerization reaction of the present invention can be carried out in the presence of a polymerizaton initiator and a polymerization accelerator.
  • a polymerizaton initiator Potassium persulfate, ammonium persulfate vitamin B 2 and Methylene Blue are suitable as polymerization initiators.
  • ⁇ -(dimethylamino)-propionitrile and N,N,N',N'-tetramethylethylenediamine are employed as polymerizaton accelerators.
  • Suitable amount of polymerization initiator to be added to the aqueous suspension of the penicillin amidase-producing microorganism are 5 to 50 mg per g of the acryloyl monomer or monomers.
  • Suitable amounts of polymerization accelerator to be added are 1.5 to 15 mg per g of the acryloyl monomer or monomers. It is preferred to carry out the reaction of 0° to 50°C, especially 20° to 40°C. The reaction may be completed within 10 to 60 minutes.
  • the acryloyl monomers which are suitable for use in the present invention include acryloylamide, N,N'-lower alkylene-bis-acryloylamide, bis(acryloylamidomethyl)ether and N,N'-di-acryloyl-ethylene-urea(N,N'-acryloyl-imidazolidine-2-one).
  • the penicillin amidase-producing microorganism with a polymer obtained from one or two monomers mentioned above, particularly with a copolymer of acryloylamide and an acryloyl monomer selected from the group consisting of N,N'-lower alkylene-bis-acryloylamide, bis(acryloylamidomethyl)ether and N,N'-di-acryloyl-ethyleneurea.
  • N,N'-methylene-bis-acryloylamide and N,N'-propylene-bis-acryloylamide are preferably employed as the N,N'-lower alkylene-bis-acryloylamide.
  • a suitable amount of N,N'-lower alkylene-bis-acryloylamide, bis(acryloylamidemethyl)ether or N,N'-acryloyl-ethylene-urea which is used to copolymerize with acryloylamide is 5 to 160 mg, especially 15 to 130 mg, more specifically 25 to 80 mg, per g of acryloylamide.
  • the resultant immobilized penicillin amidase-producing microorganism is granulated by passing it through a sieve to form particles of 2.5 to 5.5 mm, especially 3 to 4 mm in diameter.
  • 6-APA can be prepared by enzymatic reaction of the immobilized penicillin amidase-producing microorganism with penicillin.
  • the enzymatic reaction is carried out at 25° to 50°C, especially at 30° to 45°C. It is preferred to carry out reaction at a pH of 7 to 9.5, especially at pH 8 to 9.
  • Any known penicillins can be used as a substrate of the present invention. Representative examples of said penicillins are shown by the following formula: ##EQU1## wherein R is an alkyl, alkenyl or aryl-alkyl group, or a group of the formula: R 1 --X--CH 2 --, R 1 is alkyl, alkenyl or aryl, and X is oxygen or sulfur.
  • the known penicillins which are employed in the present invention include Penicillin G(benzylpenicillin), Penicillin K(n-heptylpenicillin), Penicillin X(p-hydroxybenzylpenicillin), Penicillin F(2-pentenylpenicillin), Dihydropenicillin F(n-amylpenicillin), Penicillin AT(allylmercaptomethylpenicillin), Penicillin BT (butylthiomethylpenicillin), Penicillin S( ⁇ -chlorocrotylmercaptomethylpenicillin) and Penicillin V(phenoxymethylpenicillin).
  • the amount of the substrate which is dissolved in an aqueous suspension of a penicillin amidase-producing microorganism is not critical in the present invention.
  • penicillin is dissolved in water at any concentration.
  • the aforementioned immobilized microorganism is suspended in the aqueous penicillin solution, and the suspension is stirred. After the reaction is completed, the mixture is filtered or centrifuged to recover the immobilized microorganism for subsequent use. 6-APA is recovered from the filtrate or supernatant solution.
  • the optimum condition for complete conversion of penicillin to 6-APA can be readily obtained by adjusting the reaction time.
  • the enzymatic reaction of the invention can be performed by a column method. The column method enables the reaction to be carried out in a successive manner.
  • the immobilized microorganism is charged into a column, and an aqueous penicillin solution is passed through the column at a suitable flow rate.
  • An aqueous solution containing 6-APA is obtained as the effluent.
  • 6-APA is recovered by a known method per se such as, for example, adjusting the effluent to a pH of 4 to 5.
  • the conversion rate of penicillin to 6-APA mainly depends upon the enzymatic potency of the immobilized microorganism, the temperature or the reaction time. In case of the column method, however, the optimum reaction condition for complete conversion of penicillin to 6-APA can be readily obtained by adjusting the flow rate of the substrate solution.
  • the immobilized microorganism of the present invention retains a high level of the enzymatic activity during the reaction. Moreover, due to the sufficient durability of the enzymatic activity thereof, the immobilized microorganism of the present invention can be used repeatedly for the enzymatic reaction.
  • the amount of 6-APA in a solution was assayed in accordance with the method described in "Industrial and Engineering Chemistry", 18, 619(1946) and “Analytical Chemistry", 33, 648(1961). That is, a 6-APA solution was adjusted to pH 2.0 with 2N-hydrochloric acid and washed with methyl-isobutylketone to remove penicillin and other contaminants. The amount of 6-APA in the aqueous layer thus obtained was first assayed colorimetrically in accordance with the Iodine Absorption Method. Then, the aqueous layer was further treated with phenylacetyl chloride to convert 6-APA to Penicillin G. The amount of 6-APA in said aqueous solution was again calculated on the basis of the anti-microbial activity thereof which was assayed in accordance with the Paper Disc Method.
  • Escherichia coli ATCC 9637 is inoculated into one liter of the medium.
  • the medium is cultivated at 30°C for 24 hours under shaking. Then, the medium is centrifuged.
  • the microbial cells thus collected show the penicillin amidase activity of 6.5 units/g. 12 g of the microbial cells are suspended in 48 ml of a physiological saline solution. 9 g of acryloylamide, 480 mg of N,N'-methylene-bis-acryloylamide, 6 ml of 5 % ⁇ -(dimethylamino)-propionitrile and 6 ml of 2.5 % potassium persulfate are added to the suspension.
  • the suspension is allowed to stand at 37°C for 30 minutes. After the reaction is completed, the suspension is filtered.
  • the stiff gel obtained is granulated by passing it through a sieve to form particles of 3 mm in diameter. 120 ml of an immobilized preparation of Escherichia coli ATCC 9637 are obtained. Penicillin amidase activity: 4.7 units/ml.
  • An immobilized preparation of Escherichia coli ATCC 9637 is prepared in the same manner as described in Example 1 -- (1). 120 ml of the immobilized preparation are charged into a 2.1 cm ⁇ 34.8 cm column. An aqueous 1 % potassium Penicillin G solution (pH 9.0) is passed through the column at 40°C at a flow rate as shown in Table 1. The percentage conversion of Penicillin G to 6-APA in the effluent is shown in Table 1.
  • Escherichia coli ATCC 11105 is inoculated into one liter of an aqueous nutrient medium (pH 7.0) containing the same ingredients as described in Example 1 -- (1).
  • the medium is cultivated at 30°C for 24 hours under shaking. Then, the medium is centrifuged.
  • the microbial cells thus collected show the penicillin amidase activity of 6.9 units/g. 12 g of the microbial cells are suspended in 48 ml of a physiological saline solution.
  • Penicillin V 10 g are suspended in 450 ml of water, and the suspension is adjusted to pH 9.0 with 2N-sodium hydroxide to dissolve Penicillin V therein. Water is added to the resultant aqueous Penicillin V solution to bring its total volume to 500 ml. The, 120 ml of the immobilized preparation of Escherichia coli ATCC 11105 are suspended in the aqueous Penicillin V solution. The suspension thus obtained is stirred for 40°C for a certain period of time. The percentage conversion of Penicillin V to 6-APA in the suspension is shown in Table 2.
  • Escherichia coli ATCC 11105 is inoculated into 1 liter of an aqueous nutrient medium (pH 7.0) containing the same ingredients as described in Example 1 -- (1).
  • the medium is cultivated at 30°C for 24 hours under shaking. Then, the medium is centrifuged.
  • the microbial cells thus collected show the penicillin amidase activity of 6.9 units/g. 12 g of the microbial cells are suspended in 48 ml of a physiological saline solution.
  • Streptomyces griseus IFO 3355 is inoculated into one liter of the medium.
  • the medium is cultivated at 30°C for 48 hours. Then, the medium is centrifuged.
  • the microbial cells thus collected show the penicillin amidase activity of 3.6 units/g.
  • 24 g of the microbial cells are suspended in 96 ml of a physiological saline solution.
  • 18 g of acryloylamide, 960 mg of N,N'-methylene-bis-acryloylamide, 12 ml of 5 % ⁇ -(dimethylamino)-propionitrile and 12 ml of 2.5 % potassium persulfate are added to the suspension. Then, the suspension is allowed to stand at 37°C for 30 minutes.
  • the stiff gel obtained is granulated by passing it through a sieve to form particles of 3 mm in diameter.
  • 240 ml of an immobilized preparation of Streptomyces griseus IFO 3355 are obtained.
  • Penicillin amidase activity 0.5 units/ml.
  • Nocardia gardneri ATCC 9604 is inoculated into one liter of an aqueous nutrient medium (pH 7.0) containing the same ingredients as described in Example 5 -- (1).
  • the medium is cultivated at 30°C for 72 hours under shaking. Then, the medium is centrifuged. The microbial cells thus collected show the penicillin amidase activity of 3.6 units/g. 24 g of the microbial cells are treated in the same manner as described in Example 5 -- (1).
  • 240 ml of an immobilized preparation of Nocardia gardneri ATCC 9604 are obtained. Penicillin amidase activity: 0.5 units/ml.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
US05/450,655 1973-03-24 1974-03-13 Process for preparing 6-aminopenicillanic acid Expired - Lifetime US3953291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JA48-33769 1973-03-24
JP48033769A JPS5247038B2 (nl) 1973-03-24 1973-03-24

Publications (1)

Publication Number Publication Date
US3953291A true US3953291A (en) 1976-04-27

Family

ID=12395642

Family Applications (1)

Application Number Title Priority Date Filing Date
US05/450,655 Expired - Lifetime US3953291A (en) 1973-03-24 1974-03-13 Process for preparing 6-aminopenicillanic acid

Country Status (9)

Country Link
US (1) US3953291A (nl)
JP (1) JPS5247038B2 (nl)
CH (1) CH593980A5 (nl)
DE (1) DE2414128B2 (nl)
DK (1) DK143165C (nl)
FR (1) FR2222436B1 (nl)
GB (1) GB1442282A (nl)
NL (1) NL163263C (nl)
SE (1) SE431768B (nl)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246346A (en) * 1978-09-05 1981-01-20 Aktiebolaget Fermenta Antibiotic and steroid transformation process
US4764467A (en) * 1982-06-18 1988-08-16 Basf Aktiengeselschaft, Preparation of an insoluble biocatalyst
US4783404A (en) * 1983-09-16 1988-11-08 Hoechst Aktiengesellschaft L-aminoacid oxidase from yeasts of the genus cryptococcus, their preparation and use

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2359202A2 (fr) * 1976-07-22 1978-02-17 Agronomique Inst Nat Rech Procede enzymatique utilisant des microorganismes inclus
DE2835875C2 (de) 1978-08-16 1981-11-26 Joachim Prof. Dr. Klein Verfahren zur Herstellung von Biokatalysatoren mit hoher mechanischer Festigkeit und hoher Beladung an enzymatisch aktiver Substanz und perlförmiger Biokatalysator

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619371A (en) * 1967-07-03 1971-11-09 Nat Res Dev Production of a polymeric matrix having a biologically active substance bound thereto
US3736230A (en) * 1969-02-17 1973-05-29 P Delin Process for producing 6-amino-penicillanic acid
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms
US3791926A (en) * 1971-10-28 1974-02-12 Tanabe Seiyaku Co Process for the production of l-aspartic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES365631A1 (es) * 1968-04-05 1971-03-16 Beecham Group Ltd Un procedimiento para la preparacion de acido 6-aminopeni- cilanico.
BE791750A (fr) * 1971-11-23 1973-05-22 Bayer Ag Penicillinacylase liee a un support et son procede de production
BE791748A (fr) * 1971-11-23 1973-05-22 Bayer Ag Procede de production d'acide 6-aminopenicillanique par ruptureenzymatique de penicillines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3619371A (en) * 1967-07-03 1971-11-09 Nat Res Dev Production of a polymeric matrix having a biologically active substance bound thereto
US3736230A (en) * 1969-02-17 1973-05-29 P Delin Process for producing 6-amino-penicillanic acid
US3791926A (en) * 1971-10-28 1974-02-12 Tanabe Seiyaku Co Process for the production of l-aspartic acid
US3767790A (en) * 1972-02-11 1973-10-23 Nat Patent Dev Corp Microorganisms

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246346A (en) * 1978-09-05 1981-01-20 Aktiebolaget Fermenta Antibiotic and steroid transformation process
US4764467A (en) * 1982-06-18 1988-08-16 Basf Aktiengeselschaft, Preparation of an insoluble biocatalyst
US4783404A (en) * 1983-09-16 1988-11-08 Hoechst Aktiengesellschaft L-aminoacid oxidase from yeasts of the genus cryptococcus, their preparation and use

Also Published As

Publication number Publication date
DK143165B (da) 1981-07-06
NL7403834A (nl) 1974-09-26
FR2222436B1 (nl) 1977-06-17
SE431768B (sv) 1984-02-27
DE2414128B2 (de) 1975-12-04
NL163263C (nl) 1980-08-15
DE2414128A1 (de) 1974-10-03
DK143165C (da) 1981-11-16
GB1442282A (en) 1976-07-14
JPS5247038B2 (nl) 1977-11-29
JPS49118892A (nl) 1974-11-13
CH593980A5 (nl) 1977-12-30
FR2222436A1 (nl) 1974-10-18
NL163263B (nl) 1980-03-17

Similar Documents

Publication Publication Date Title
US3687926A (en) Surfactin
US3791926A (en) Process for the production of l-aspartic acid
EP0054800B1 (en) Process for the production of immobilized microorganisms
US3953291A (en) Process for preparing 6-aminopenicillanic acid
US3886040A (en) Novel Process for preparing L-citrulline
US3922195A (en) Process for preparing L-Malic acid
US4081327A (en) Preparation of d-fructose
JP2950896B2 (ja) D―α―フェニルグリシンの製造法
US5284754A (en) Process for the continuous conversion of cephalosporin derivatives into glutaryl-7-aminocephalosporanic acid derivatives
US3898128A (en) Process for preparing L-alanine
US3607648A (en) Method for the production of d-ribose
JPS5922516B2 (ja) L−フエニルアラニンの製造法
US4486532A (en) Process for preparing L-malic acid
IE45997B1 (en) Process for preparing 6-aminopenicillanic acid
US3787288A (en) Method for preparing alpha-aminobenzylpenicillin
US3898127A (en) Process for preparing urocanic acid
US3627639A (en) Process for producing l-asparaginase
US5015579A (en) Production of (-)trans-2,3-epoxysuccinic acid by fermentation
US3853705A (en) Enzymatic production of cephalothin
US5723321A (en) Process for preparing D-lysine
KR910007850B1 (ko) 고농도 아크릴로니트릴로부터의 아크릴아마이드의 제조 방법 및 이에 이용되는 미생물
JP2655618B2 (ja) 微生物凝集剤noc―1の製造方法
RU2420581C1 (ru) Способ получения биокатализатора, обладающего активностью в отношении синтеза цефалоспоринов-кислот
JPH07284395A (ja) L−リンゴ酸重合物の製造法
JPS63157990A (ja) L−α−メチルフエニルアラニン類の製造法